Literature DB >> 8501091

Total hip replacement without cement for non-inflammatory osteoarthrosis in patients who are less than forty-five years old.

M A Mont1, D C Maar, K A Krackow, M A Jacobs, L C Jones, D S Hungerford.   

Abstract

Forty-two patients (forty-four hips) who, at an age of less than forty-five years, had a total hip replacement without cement for the treatment of non-inflammatory osteoarthrosis, were followed for three to seven years (average, four and one-half years). At the latest follow-up evaluation, thirty-seven hips (84 per cent) had an excellent Harris rating; three (7 per cent), good; one (2 per cent), fair; and three (7 per cent), poor. The mean Harris hip score was 92 points, compared with 43 points before the operation. Two hips (5 per cent) had a revision due to complications. In another hip, there was a progressive radiolucent line around the femoral component, increased shedding of beads, and a low score for fixation and stability, according to the criteria of Engh et al. We concluded that total hip arthroplasty without cement, at least for the time-period studied, has a high rate of success for the management of patients less than forty-five years old who have non-inflammatory osteoarthrosis of the hip.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8501091     DOI: 10.2106/00004623-199305000-00015

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  10 in total

1.  The dimensional accuracy of preparation of femoral cavity in cementless total hip arthroplasty.

Authors:  Li-dong Wu; H J Hahne; J Hassenpflug
Journal:  J Zhejiang Univ Sci       Date:  2004-10

2.  Complications in shoulder arthroplasty: an analysis of 485 cases.

Authors:  Peter R Aldinger; Patric Raiss; Markus Rickert; Markus Loew
Journal:  Int Orthop       Date:  2009-04-28       Impact factor: 3.075

3.  Durability of second-generation extensively porous-coated stems in patients age 50 and younger.

Authors:  Jennifer A Moyer; Catherine M Metz; John J Callaghan; David W Hennessy; Steve S Liu
Journal:  Clin Orthop Relat Res       Date:  2009-09-01       Impact factor: 4.176

4.  Uncemented and custom made hip prostheses in patients younger than 50 years.

Authors:  J -N Argenson; Ph Paris; E Bonis; J -M Aubaniac
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-10

5.  Uncemented porous-coated anatomic total hip replacement in Chinese patients.

Authors:  K H Chiu; W Y Shen; K M Chan
Journal:  Int Orthop       Date:  1995       Impact factor: 3.075

6.  Low wear rates seen in THAs with highly crosslinked polyethylene at 9 to 14 years in patients younger than age 50 years.

Authors:  Kevin L Garvin; Tyler C White; Anand Dusad; Curtis W Hartman; John Martell
Journal:  Clin Orthop Relat Res       Date:  2015-12       Impact factor: 4.176

7.  Results of Primary Total Hip Arthroplasty Using 36 mm Femoral Heads on 1st Generation Highly Cross Linked Polyethylene in Patients 50 Years and Less with Minimum Five Year Follow-up.

Authors:  Won-Kee Choi; Myung-Rae Cho; Hee-Soo Kim; Jun-Ho Nam; Seung-Bum Chae
Journal:  Hip Pelvis       Date:  2016-06-30

8.  Survivorship of monoblock trabecular metal cups in primary THA : midterm results.

Authors:  Konstantinos N Malizos; Konstantinos Bargiotas; Loukia Papatheodorou; Michael Hantes; Theofilos Karachalios
Journal:  Clin Orthop Relat Res       Date:  2008-01-03       Impact factor: 4.176

9.  Results of Total Hip Arthroplasty with 36-mm Metallic Femoral Heads on 1st Generation Highly Cross Linked Polyethylene as a Bearing Surface in Less than Forty Year-old Patients: Minimum Ten-year Results.

Authors:  Won Kee Choi; Jae Jung Kim; Myung-Rae Cho
Journal:  Hip Pelvis       Date:  2017-12-01

10.  Clinical and radiographic outcomes of a trabecular titanium™ acetabular component in hip arthroplasty: results at minimum 5 years follow-up.

Authors:  Loris Perticarini; Giacomo Zanon; Stefano Marco Paolo Rossi; Francesco M Benazzo
Journal:  BMC Musculoskelet Disord       Date:  2015-12-03       Impact factor: 2.362

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.